Maureen Smythe, Pharm.D.

Professor (Clinical)

Office Location

EACPHS, Room 4126

313-577-5384

Pharmacy Practice

2017 - Wayne State University Distinguished Alumni Award
2016 - Preceptor of Student Community Research Award
2016 - WSU Student Research Awards
2012 - Outstanding Achievement in Clinical Sciences Research, Wayne State University
2007 - Preceptor of the Year, William Beaumont Hospital
2005 - Teacher of the Year, Wayne State University, Professional 3rd year class
2004 - Teacher of the Year, Wayne State University, Professional 3rd year class

Refereed Journals

Smythe MA, Koerber JM, Roberts AM, Hoffman JL, Batke J. Preventability of Hospital Acquired Venous Thromboembolism, submitted to Joint Commission, Journal on Quality and Patient Safety, submitted.

Smythe MA, Hoffman JL, Koerber JM, Mertz S, Fritsch K, Chehab F et al. Outcomes of activated prothrombin complex concentrate for direct Xa inhibitor bleeding; Thrombosis Research 2021; 206 142-144.

Smythe MA, Burns C, Liu Q, Garwood CL. Potential dexamethasone-direct oral anticoagulant drug interaction, is this a concern in COVID? Ann Pharmacother 2022; 56 (3):319-329

Warkentin TE, Smythe MA, Ali MA et al. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? Am J Hematol 2020; 1-10

Rimsans J, Douxfils J, Smythe MA, Gosselin C. Overview and application of coagulation assays in managing anticoagulation with direct oral anticoagulants, Current Pharmacol Report 2020;6:241-259

Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, Khan SR, RahmanM, Rajasekhar A, Rogers FB, Smythe MA, Tikkinen KAO, Yates AJ, Baldeh T Balduzzi S, Brozek JL, Ikobaltzeta IE, Johal H, Neumann I, Wiercioch W, Yepes, NunezJJ,Schunemann HJ, Dahm P. American Society of Hematology 2019 guidelines for the management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients, Blood Adv 2019; 3(23):3898-3944.

Smythe MA, Parker D Jr, Garwood CL, Cuker A, Messe SR. Timing of initiation of oral anticoagulation after acute ischemic stroke in patients with atrial fibrillation, Pharmacother 2019;10(3):23:389-44.

Abstracts

Mertz S, Chehab F, Koerber JM, Hoffman JL, Smythe MA. Anti-inhibitor coagulant complex for hemorrhage reversal in patients taking apixaban or rivaroxaban, Crit Care Med 2020,48 (1):241

Koerber JM, Fritsch K, Hoffman JL, Mertz S, Baalbaki N, Chehab F, Smythe MA. Characteristics, management and outcomes of patients receiving activated prothrombin complex concentrate for apixaban and rivaroxaban associated major bleeding, Am J Hematol 2020, In Press.